scispace - formally typeset
V

Veronica Codullo

Researcher at University of Pavia

Publications -  82
Citations -  2503

Veronica Codullo is an academic researcher from University of Pavia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 66 publications receiving 1912 citations. Previous affiliations of Veronica Codullo include University of Pisa.

Papers
More filters
Journal ArticleDOI

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

TL;DR: The comparison of RTX treated versus untreated matched-control SSc patients from the EUSTAR cohort demonstrated improvement of skin fibrosis and prevention of worsening lung fibrosis, supporting the therapeutic concept of B cell inhibition in SSc.
Journal ArticleDOI

Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse

TL;DR: In a cohort of early RA patients treated with conventional DMARDs, US-GS can detect residual disease activity more sensitively than clinical examination both in active disease and in remission and PD-positive synovial hypertrophy identifies an ongoing inflammation even during remission and predicts short-term relapse.
Journal ArticleDOI

B cells in rheumatoid arthritis.

TL;DR: Being much more than simple autoantibody producers, B cells are able to secrete many important cytokines and to efficiently present antigens to T lymphocytes in the synovial environment, and lately have claimed attention as B cell depletion has become a common and effective strategy of treatment in RA.
Journal ArticleDOI

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

Lorenzo Cavagna, +113 more
TL;DR: Survition was not influenced by the underlying anti-aminoacyl tRNA synthetase antibodies’ positivity, which confirmed that antisynthetase syndrome is a heterogeneous condition and that antibody specificity only partially influences the clinical presentation and evolution of this condition.